Effect of vitamin D levels on natural killer cells in diabetes mellitus patients with tuberculosis

M. Ponnana, R. Sivangala, L. Joshi, S. Thada, V. L. Valluri, S. L. Gaddam (Hyderabad, India)

Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Session: Tuberculosis: from epidemiology to therapy 3
Session type: Thematic Poster Session
Number: 2685
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Ponnana, R. Sivangala, L. Joshi, S. Thada, V. L. Valluri, S. L. Gaddam (Hyderabad, India). Effect of vitamin D levels on natural killer cells in diabetes mellitus patients with tuberculosis. Eur Respir J 2014; 44: Suppl. 58, 2685

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Vitamin D levels in patients with a clinical diagnosis of tuberculosis
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013


Latent mycobacterium tuberculosis infection among type 2 diabetes mellitus patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Impact of diabetes on the presenting features of tuberculosis patients
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Screening of diabetes mellitus among new cases of tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Prevalence of diabetes mellitus in new tuberculosis cases in Baghdad
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Tuberculosis with diabetes mellitus: Does delayed sputum conversion always needs MDR evaluation?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Are we effectively monitoring and treating vitamin D deficient patients with tuberculosis?
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013

Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016

A study of immunogenetic markers associated With tuberculosis and diabetes mellitus
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013

Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Vitamin D supplementation in health and latent tuberculosis promotes regulatory T cell expression
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016